Axsome Therapeutics (AXSM) FCF/share US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -2.89 | -2.88 | -3.21 | -2.69 | -1.89 | -1.39 | |||
| Changes by years, y/y, % | +37% | 0% | +11% | -16% | -30% | -2.2% | |||
Axsome Therapeutics. FCF/share, rub
Axsome Therapeutics. FCF/share, changes, %
Axsome Therapeutics (AXSM) FCF/share US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF/share, rub | -0.89 | -0.66 | 0.02 | -0.37 | -0.41 | -1.39 | ||
| Changes by years, y/y, % | -21% | +3% | -105% | -32% | -55% | |||
| Changes by quarters, q/q, % | +66% | -27% | -103% | -1 972% | +10% | |||